Agreement Supported by a Substantial Majority of Each of its First and Second Lien Debtholders and Opioid Trust
Financial Restructuring Plan to Significantly Reduce Debt, Increase Free Cash Flow Generation, Extend Maturity Runway and Better Position Company for Long-Term Success
Intends to Initiate Voluntary Prepackaged Chapter 11 Proceedings to Implement Plan
Continuing to Deliver High-Quality Therapies to Patients and Serve Customers; Vendors and Suppliers to be Paid in Full in the Ordinary Course
DUBLIN, Aug. 23, 2023 /PRNewswire/ — Mallinckrodt plc (NYSE American: MNK) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced it has entered into a Restructuring Support Agreement (“RSA”) with a su…
Read the full article at: https://finance.yahoo.com/news/mallinckrodt-plc-enters-restructuring-support-122200453.html